Exploring the critical second genetic event that transforms BRCA susceptibility into breast cancer malignancy, with insights into mechanisms, clinical implications, and future research directions.
Exploring how E-cadherin loss in breast cancer drives invasion through methylation, mutations, and cadherin switching, with diagnostic and therapeutic implications.